In this study, CTCs in peripheral blood of HCC patients were enriched by innovative multi-site immunoliposomes (IML) for immunofluorescence identification, were labeled by GPC3 (a subtype of HSPG) antibody-coated magnetic particles, and then were separated immunomagnegically. Here, GPC3 is linked to hepatocellular carcinoma.